Compare MIST & ZEPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MIST | ZEPP |
|---|---|---|
| Founded | 2003 | 2013 |
| Country | Canada | Netherlands |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Manufacturing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 176.3M | 202.9M |
| IPO Year | 2019 | 2017 |
| Metric | MIST | ZEPP |
|---|---|---|
| Price | $1.50 | $10.15 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 83.8K |
| Earning Date | 05-13-2026 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2,915.14 | $778.34 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.00 | $2.22 |
| 52 Week High | $3.06 | $61.50 |
| Indicator | MIST | ZEPP |
|---|---|---|
| Relative Strength Index (RSI) | 33.77 | 33.80 |
| Support Level | $1.40 | N/A |
| Resistance Level | $2.01 | $30.26 |
| Average True Range (ATR) | 0.12 | 1.78 |
| MACD | -0.05 | -0.74 |
| Stochastic Oscillator | 6.36 | 6.82 |
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
Zepp Health Corp is engaged in the business of manufacturing smart health wearable products. The company operates in one segment which is Amazfit-branded products. The product portfolio includes smartwatches and fitness bands.